London South East Oil & Gas Investor Briefing with guests from Coro Energy & Eco Atlantic Oil & Gas - Book Now

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,641.80
Bid: 1,641.60
Ask: 1,642.00
Change: -4.40 (-0.27%)
Spread: 0.40 (0.02%)
Open: 1,644.40
High: 1,648.60
Low: 1,620.00
Yest. Close: 1,646.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

BROKER RATINGS SUMMARY: Deutsche Bank Starts Taylor Wimpey At Buy

Tue, 3rd Sep 2019 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:



FTSE 100



DEUTSCHE BANK INITIATES TAYLOR WIMPEY WITH 'BUY' - TARGET 187 PENCE



DEUTSCHE BANK RESUMES BARRATT DEVELOPMENTS WITH 'HOLD' - TARGET 648 PENCE



DEUTSCHE BANK RESUMES BERKELEY GROUP WITH 'SELL' - TARGET 3428 PENCE



DEUTSCHE BANK RESUMES PERSIMMON WITH 'BUY' - TARGET 2386 PENCE



BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 603 (600) PENCE - 'OVERWEIGHT'



BARCLAYS RAISES PRUDENTIAL PRICE TARGET TO 2088 (2069) PENCE - 'OVERWEIGHT'



BARCLAYS CUTS PHOENIX GROUP PRICE TARGET TO 657 (664) PENCE - 'EQUAL WEIGHT'



BARCLAYS RAISES LEGAL & GENERAL PRICE TARGET TO 331 (320) PENCE - 'OVERWEIGHT'



BARCLAYS RAISES HISCOX PRICE TARGET TO 1556 (1514) PENCE - 'UNDERWEIGHT'



BARCLAYS CUTS DIRECT LINE PRICE TARGET TO 347 (354) PENCE - 'EQUAL WEIGHT'



BARCLAYS RAISES AVIVA PRICE TARGET TO 551 (550) PENCE - 'OVERWEIGHT'



BARCLAYS CUTS ADMIRAL GROUP PRICE TARGET TO 2288 (2314) PENCE - 'OVERWEIGHT'



CITIGROUP REINITIATES GLAXOSMITHKLINE WITH 'NEUTRAL' - PRICE TARGET 1840 PENCE



UBS CUTS WM MORRISON SUPERMARKETS PRICE TARGET TO 245 (260) PENCE - 'BUY'



UBS CUTS MICRO FOCUS PRICE TARGET TO 1530 (2050) PENCE - 'BUY'



FTSE 250



BOFA CUTS ASHMORE GROUP TO 'NEUTRAL' ('BUY')



UBS CUTS PAGEGROUP PRICE TARGET TO 440 (495) PENCE - 'NEUTRAL'



UBS CUTS HAYS PRICE TARGET TO 140 (165) PENCE - 'NEUTRAL'



DEUTSCHE BANK RESUMES BELLWAY WITH 'BUY' - TARGET 3538 PENCE



DEUTSCHE BANK RESUMES BOVIS HOMES WITH 'HOLD' - TARGET 1085 PENCE



DEUTSCHE BANK RESUMES MCCARTHY & STONE WITH 'HOLD' - TARGET 137 PENCE



DEUTSCHE BANK RESUMES COUNTRYSIDE PROPERTIES WITH 'BUY' - TARGET 353 PENCE



DEUTSCHE BANK RESUMES REDROW WITH 'BUY' - TARGET 728 PENCE



KEPLER CHEUVREUX CUTS EASYJET TO 'REDUCE' (HOLD) - PRICE TARGET 820 (1200) PENCE



BARCLAYS CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 727 (731) PENCE - 'EQUAL WEIGHT'



BARCLAYS RAISES HASTINGS GROUP PRICE TARGET TO 225 (220) PENCE - 'OVERWEIGHT'



GOLDMAN SACHS RAISES GVC HOLDING PRICE TARGET TO 1000 (950) PENCE - 'BUY'



OTHER MAIN MARKET AND AIM



LIBERUM RAISES AB DYNAMICS PRICE TARGET TO 3085 (2750) PENCE - 'BUY'



More News

TOP NEWS: GlaxoSmithKline Sells Two Vaccines Amid Growth Assets Focus

TOP NEWS: GlaxoSmithKline Sells Two Vaccines Amid Growth Assets Focus

Today 08:16

GlaxoSmithKline offloads two travel vaccines to Bavarian Nordic

(Sharecast News) - GlaxoSmithKline announced the divestment of travel vaccines 'Rabipur', known as Rabavert in the US and used for the prevention of rabies, and 'Encepur' for the prevention of tick-borne encephalitis, to Bavarian Nordic on Monday.

Today 08:10

Teva's UK arm recalls some batches of Ranitidine - Medicines watchdog

Oct 17 (Reuters) - Teva Pharmaceutical's UK unit has recalled some batches of heartburn medicine Ranitidine, Britain's medicines watchdog said on Thursday, making it the latest drugmaker to pull the product.Teva, the world's largest generic drugma...

17 Oct 19 15:50

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

14 Oct 19 11:06

UK BROKER RATINGS SUMMARY: Shore Cuts Asos To Sell From Hold

UK BROKER RATINGS SUMMARY: Shore Cuts Asos To Sell From Hold

14 Oct 19 09:23

UPDATE 1-FTSE falters as Brexit hopes lift pound; domestic stocks rejoice

* FTSE 100 down 0.3%, FTSE 250 up 0.8%* Brexit deal hopes lift sterling, hit exporters* Housebuilders, UK banks jump* WPP, Burberry fall after European rivals cut forecast* Dart Group climbs higher after hiking profit view (Adds news items, analyst ...

11 Oct 19 09:07

UPDATE 1-British blue-chips trail Europe as Brexit deal hopes lift pound

* FTSE 100 up 0.1%, FTSE 250 down 0.1%* GVC gains after forecast upgrade* Just Eat tops blue-chip risersBy Muvija M and Shashwat AwasthiOct 9 (Reuters) - London's exporter-laden FTSE 100 lagged its European peers on Wednesday, as sterling gained on ...

9 Oct 19 10:21

UPDATE 1-GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

(Adds context on U.S. FDA move)Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.The mo...

8 Oct 19 16:53

UPDATE 2-GSK recalls prescription-only versions of heartburn drug Zantac

* Four products recalled; over-the-counter ones not affected* UK regulator says recall a "precautionary measure"* Regulators investigating ranitidine drugs for impurities (Adds details on products affected, context on other drugmakers halting suppl...

8 Oct 19 16:53

UPDATE 3-GSK recalls popular heartburn drug Zantac globally after cancer scare

* GSK recalls Zantac products in all markets as a "precaution"* Four products recalled; OTC ones not affected -UK regulator* GSK says working with regulators to address concerns (Tweaks headline, first paragraph; adds company comment)By Justin Geo...

8 Oct 19 16:53

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

8 Oct 19 16:33

GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.GSK is recalling all unexpired stock ...

8 Oct 19 16:25

UPDATE 2-Trade hopes lift FTSE 100, SIG drags down mid-caps

* FTSE 100 up 0.6%, FTSE 250 dips 0.3%* Hopes for U.S.-China deal help blue-chips* Mid-cap SIG plummets after profit warning (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiOct 7 (Reuters) - Oil majors led a rebound in ...

7 Oct 19 09:29

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

4 Oct 19 17:31

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

4 Oct 19 14:24

Login to your account

Don't have an account? Click here to register.